⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2907140 | 0.84 | SLC6A12 (0.41) | — | |
| SCHEMBL9517474 | 0.84 | SLC6A12 (0.41) | — | |
| SCHEMBL1830399 | 0.83 | — | — | |
| SCHEMBL14249941 | 0.81 | — | — | |
| SCHEMBL31293261 | 0.79 | SLC6A12 (0.40) | — | |
| SCHEMBL16037148 | 0.79 | SLC6A12 (0.40) | — | |
| SCHEMBL6046425 | 0.76 | — | — | |
| SCHEMBL24483431 | 0.73 | ANPEP (0.56) | — | |
| SCHEMBL28300354 | 0.73 | ANPEP (0.56) | — | |
| SCHEMBL24197646 | 0.73 | ANPEP (0.56) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023062342-A1 | FRAGRANCE AND DISPENSER | Reckitt & Colman (Overseas) Hygiene Home Limited (GB) | 2023-04-20 | — | — | WO | disclosed |
| WO-2017064527-A1 | CLEANING FORMULATIONS WITH IMPROVED PERFORMANCES | RHODIA POLIAMIDA E ESPECIALIDADES LTDA (BR) | 2017-04-20 | — | — | WO | disclosed |
| CN-102099356-A | Heterocyclic derivatives as modulators of ion channels | VERTEX PHARMA | 2011-06-15 | — | — | CN | disclosed |
| CN-101365686-A | Heterocyclic derivatives as modulators of ion channels | VERTEX PHARMA (US) | 2009-02-11 | — | — | CN | disclosed |
| CN-1915968-A | Neutral-cationic lipid for nucleic acid and drug delivery | ALZA CORP (US) | 2007-02-21 | — | — | CN | disclosed |
| EP-1578723-A4 | PROCESS FOR THE PREPARATION OF OXAZOLIDINONES AND METHOD OF USE THEREOF | UNIV MICHIGAN STATE (US) | 2006-11-02 | — | — | EP | disclosed |
| EP-1578723-A3 | PROCESS FOR THE PREPARATION OF OXAZOLIDINONES AND METHOD OF USE THEREOF | MICHIGAN STATE UNIVERSITY (US) | 2005-10-20 | — | — | EP | disclosed |
| EP-1578723-A2 | PROCESS FOR THE PREPARATION OF OXAZOLIDINONES AND METHOD OF USE THEREOF | MICHIGAN STATE UNIVERSITY (US) | 2005-09-28 | — | — | EP | disclosed |
| CN-1193059-C | Neutral lipopolymer and liposome composition containing same | ALZA CORP (US) | 2005-03-16 | — | — | CN | disclosed |
| WO-2003106413-A2 | PROCESS FOR THE PREPARATION OF OXAZOLIDINONES AND METHOD OF USE THEREOF | MICHIGAN STATE UNIVERSITY (US) | 2003-12-24 | — | — | WO | disclosed |
| EP-1322599-A2 | HIV INTEGRASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2003-07-02 | — | — | EP | disclosed |
| CN-1378536-A | Neutral-cationic lipids for nucleic acid and drug delivery | ALZA CORP (US) | 2002-11-06 | — | — | CN | disclosed |
| WO-2001096283-A9 | HIV INTEGRASE INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2002-10-17 | — | — | WO | disclosed |
| CN-1360611-A | Neutral lipopolymer and liposomal compositions contg. same | ALZA CORP (US) | 2002-07-24 | — | — | CN | disclosed |
| WO-2001096283-A2 | HIV INTEGRASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2001-12-20 | — | — | WO | disclosed |